Are unknown co-medications, over-the-counter and off-label drug use still problems among people living with HIV? Results from a transversal survey in 23 centres in France.

Macha Tetart,Priscila Passecountrin,Anaïs Lesourd,Diane Sanderink,Gwenaël Le Moal,Laure Surgers,Guillaume Beraud,Christine Katlama,Olivier Robineau,Jean-Jacques Parienti

The Journal of antimicrobial chemotherapy（2023）

引用 0|浏览8

暂无评分

摘要

Potential DDIs that lead to therapeutic modifications remain significant whatever the age of PLHIV. More devoted time to identify co-medications and OTC treatment is needed in all PLHIV.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要